GLP-1 and Diabetes
2 articles in this topic.
GLP-1 and Diabetes
SURPASS Trials: Tirzepatide's Diabetes Results
The SURPASS program tested tirzepatide against placebo, semaglutide, and insulin across 6 trials. Up to 97% hit HbA1c targets. Here are the results.
13 min read|Mar 25, 2026
GLP-1 and Diabetes
GLP-1 Agonists for Type 2 Diabetes Explained
GLP-1 receptor agonists lower blood sugar through glucose-dependent insulin release, glucagon suppression, and slowed gastric emptying. The mechanism explained.
13 min read|Mar 22, 2026